Posters

 

2019

January

McMeekin N, Briggs A, Wu O A methodological framework for developing conceptual models‌ in economic evaluation. HESG Winter 2019, York, England 

 

2018

 

June

Geue C, Hawkins N, A Bayesian Approach to Explore and Improve Methodologies for the Identification and Estimation of Subgroup Effects in Clinical Trials. SMDM 2018, Leiden‌

Baba C, Briggs A, McIntosh E,  Informing the Design of a New Preference Weighted Value Framework for Oncology: A Mixed Methods Approach SMDM 2018, Leiden

  

2017

November 

Baba C., Briggs A., McIntosh E. Identifying attributes of cancer treatments : What do stakeholders consider? ISPOR 20th Annual European Congress, Glasgow, UK. November 2017

Baba C., Grieve E., McIntosh E. An economic evaluation of 'delivering assisted lifestyles at scale' (dallas). ISPOR 20th Annual European Congress, Glasgow, UK. November 2017.

Bouttell J., Briggs A., Hawkins N. Identifying cost-effective methods of health technology assessment for developers. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017.

Bouttell J., Lewsey, J.Synthetic Control Methodology  guide to the method and case study. Lancet Public Health Science Conference, London, UK. November 2017.

Briggs A. Cost-effectiveness of Nivolumab (NIVO) combined with Ipilimumab (IPI) compared with NIVO and IPI monotherapies in the first-line treatment of advanced melanoma in the United States: analysis using 28-month overall survival (OS) data from checkmate 067. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017. 

Briggs A. The validity of objective response rate as a surrogate for progression-free and overall survival in the evaluation of first-line chemotherapy for advanced non-small cell lung cancer. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017. 

Briggs A. Economic evaluation of single inhaler triple therapy for patients with chronic obstructive pulmonary disease (COPD) using the Galaxy model. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017. 

Briggs A. A conceptual model of the economics of visualization in diagnostics and surgery. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017.

Briggs A., Baba C., McIntosh E. But will they trade health? Developing an economic value framework for oncology Developing an economic value framework for oncology.ISPOR 20th Annual European Congress, Glasgow, UK. November 2017. 

Heggie R. How should we test for pre-term labour? An IPD meta-analysis and economic model. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017.

Heggie R., Wu O. Cost-effectiveness of mechanical thrombectomy compared with standard treatment‌ in patients with acute ischaemic strokeISPOR 20th Annual European Congress, Glasgow, UK. November 2017.

Kohli-Lynch CN. Long-term benefits of LDL cholesterol lowering in young adulthood: A computer simulation study. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017.

Kohli-Lynch CN. Cost-effectiveness of statin prioritisation based on absolute risk reduction for primary prevention of cardiovascular disease.  ISPOR 20th Annual European Congress Glasgow, UK. November 2017.

Lewsey J., Bouttell J. Investigating age-period-cohort effects using Lexis diagrams and intrinsic estimator regression modelling to understand Scotland’s ‘excess mortality’. Lancet Public Health Science Conference, London, UK. November 2017.

McIntosh E. The economics of assets in public health. University of Glasgow Capabilities Group, Glasgow, UK. November 2017.

McIntosh E. Workshop: Editorial support to the 6th book in the OUP series of Handbooks in Health Economics. Brocher Foundation, Lake Geneva, Switzerland. November 2017.

McMeekin N. Briggs A., Wu O.DDeveloping a conceptual modelling framework for economic evaluation. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017.

Rezaei Hemami M., Boyd K. Cost-effectiveness of intelligent Liver Function test(iLFT) for investigation of patients with abnormal liver function tests. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017.

Ryan C., Wu O. Capturing patient perspectives in the evaluation of medical devices: the case of central venous access devices in chemotherapy. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017.*

Xin Y., Lewsey J., McIntosh E. Too broad to be sensitive? Exploring the responsiveness of the ICECAP-O capability wellbeing measure compared to the EQ-5D-3L to the change of clinical and QoL aspects in people with Parkinson’s. ISPOR 20th Annual European Congress, Glasgow, UK. November 2017.

 

  

2016

Wu O, McMeekin N, Hawkins N.  Lost in Translation: randomised controlled trial and systematic review evidence of intracoronary vs intravenous abciximab in ST-elevation myocardial infarcion.  ISPOR 2016, Vienna.

Ciminata G, Geue C, Wu O, Langhorne P.  The prescribing, inpatient, outpatient and Social care costs associated with atrial fibrillation in Scotland

 

2015

Boyd, K.A., McIntosh, E.,   Cost-effective management of bronchiolitis in infants : 90% versus 94% oxygen saturation, European Respiratory Society International Congress  September 2015,  Amsterdam, 


Presentations

2019

February 

Boyd K  Health Economic considerations for Evaluating Secure Care in Scotland, Stirling UK

2018

October 

Boutell J. Test and treatment threshold plot: developing a simple tool to estimate required test performance for developers of tests for treatment response. Methods for the economic evaluation of diagnostics (MEED) research forum. Leeds, UK.

Germeni E. Updating a meta-ethnography on primary care antibiotic prescribing: Key considerations and lessons learnt. 24th Annual Qualitative Health Research (QHR) Conference. Halifax, Canada.

Geue C. Costs of Prevalent and Incident Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Scotland using Routinely Collected Data. Mount Hood Diabetes Challenge, Berlin, Germany. 

Hagpanahan H. Are tobacco control mass media campaigns effective and cost-effective? A population level analysis in Scotland. Priorities 2018: 12th International Society on Priorities in Health (ISPH). Linkoping, Sweden. 

LewseyJ., Geue C. Developing a Scottish T2DM Policy Model and a web-based decision aid “dashboard.  Mount Hood Diabetes Challenge, Dusseldorf, Germany.

 

September 


Boutell J. Review of colorectal cancer service change – introduction of universal KRAS/NRAS/BRAF testing. Glasgow Molecular Pathology Node Annual Symposium, Glasgow, UK. 

Germeni, E. Tackling inappropriate antibiotic prescribing for ARTIs in primary care: What can we learn from published qualitative research? Tackling inappropriate antibiotic prescribing for ARTIs in primary care: What can we learn from published qualitative research. 16th International Conference on Communication in Healthcare (ICCH, Porto, Portugal. 

Hsieh P. The evolving drug expenses and healthcare cost of rheumatoid arthritis: a systematic review. 78th International Pharmaceutical Federation (FIP) World Congress, Glasgow, UK.  

Hsieh P. The evolving cost of illness of rheumatoid arthritis: a systematic review.  8th ISPOR Asia Pacific Conference, Tokyo, Japan.  2018

Lewsey J., Haghpanahan H., Sim M. Disseminated quantitative drink drive evaluation results to key stakeholders. Edinburgh, UK. 

 

July

Boyd K. Economic Evaluation in Public Health and Complex Interventions: UK & European Perspectives Thai Health Promotion Foundation Conference, Bangkok, Thailand  

Haghpanan H.  Are Tobacco Control Mass Media Campaigns Effective and Cost-effective?  A population level analysis. EuHEA 2018,  Maastricht

McMeekin NDeveloping a conceptual modelling framework for economic evaluation =, EuHEA 2018,  Maastricht, Netherlands

Deidda M. Methodological challenges conducting economic evaluations alongside natural experiments: the Healthy Start Voucher case study, EUHEA 2018, Maastricht, Netherlands.

Robles Zurito, Jose-Antonio. From normal to overweight without noticing: a relative plausible explanation. EUHEA 2018, Maastricht

Robles Zurito, Jose-Antonio. Economic evaluation of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. EuHEA 2018,  Maastricht, Netherlands.

 

May

Wu O.  Health Technology Assessment of Alternative and Traditional Medicines  HTAsialink, Bangkok, Thailand

 

2017 

Bouttell JLaboratory Medicine Grand Rounds Queen Elizabeth University Hospital, Glasgow UK. November 2017

Briggs A. Educational symposium: Practical implications of value-based pricing and emerging value frameworks in health technology assessment. ISPOR 20th Annual European Congress, Glasgow, UK.

Briggs A. Workshop:Determining the value of long-term outcomes associated with immuno-oncology therapies- challenges and approaches for OS extrapolations. ISPOR 20th Annual European Congress, Glasgow, UK. N

Haghpanahan H., Boyd K., McIntosh E.Effectiveness and Cost effectiveness of Tobacco Control Mass Media Campaigns ISPOR 20th Annual European Congress, Glasgow, UK. 

Kohli-Lynch CN.  A framework for the cost-effectiveness analysis of novel biomarker testing in cardiovascular disease. ISPOR 20th Annual European Congress, Glasgow, UK. 

Lewsey J., Bouttell J. Investigating age-period-cohort effects using Lexis diagrams and intrinsic estimator regression modelling to understand Scotland’s ‘excess mortality’. Lancet Public Health Science Conference, London, UK. 

McIntosh E. The economics of assets in public health. University of Glasgow Capabilities Group, Glasgow, UK. 

McIntosh E. Workshop: Editorial support to the 6th book in the OUP series of Handbooks in Health Economics. Brocher Foundation, Lake Geneva, Switzerland.